Tao Song

1.4k total citations
40 papers, 969 citations indexed

About

Tao Song is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Tao Song has authored 40 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 23 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Tao Song's work include MicroRNA in disease regulation (20 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (14 papers). Tao Song is often cited by papers focused on MicroRNA in disease regulation (20 papers), Circular RNAs in diseases (15 papers) and Cancer-related molecular mechanisms research (14 papers). Tao Song collaborates with scholars based in China, United States and Russia. Tao Song's co-authors include Weifeng Mao, Jintao Lin, Cong Li, Wei Cai, Yiguang Wu, Chunyang Wang, Ningsheng Shao, Wei Xia, Xu Zhang and Bao-fa Hong and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Fertility and Sterility and Neurobiology of Aging.

In The Last Decade

Tao Song

39 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Song China 19 699 534 102 100 76 40 969
Han He China 12 579 0.8× 292 0.5× 125 1.2× 87 0.9× 88 1.2× 26 913
Gina N. Alesi United States 7 612 0.9× 474 0.9× 71 0.7× 148 1.5× 124 1.6× 9 898
Yingjie Xia China 18 532 0.8× 394 0.7× 100 1.0× 162 1.6× 123 1.6× 28 819
Yongsheng Zhang China 19 604 0.9× 366 0.7× 72 0.7× 157 1.6× 89 1.2× 46 879
Xuelei Ruan China 23 988 1.4× 787 1.5× 76 0.7× 78 0.8× 74 1.0× 49 1.2k
Qiong Xu China 13 550 0.8× 288 0.5× 90 0.9× 96 1.0× 53 0.7× 29 724
Xiuying Zhong China 13 814 1.2× 564 1.1× 57 0.6× 96 1.0× 77 1.0× 16 1.1k
Erjie Xia China 17 565 0.8× 423 0.8× 70 0.7× 134 1.3× 136 1.8× 52 789

Countries citing papers authored by Tao Song

Since Specialization
Citations

This map shows the geographic impact of Tao Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Song more than expected).

Fields of papers citing papers by Tao Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Song. The network helps show where Tao Song may publish in the future.

Co-authorship network of co-authors of Tao Song

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Song. A scholar is included among the top collaborators of Tao Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Song. Tao Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yanqing, Tao Lu, Ying Wang, et al.. (2025). Beyond mTOR: Unraveling the Complex Pathophysiology and Signaling Pathways in Focal Cortical Dysplasia. Molecular Neurobiology. 63(1). 171–171.
2.
Zhang, Yingying, et al.. (2023). FGF13A interacts with NPM1 and UBF and inhibits the invasion of bladder cancer cells. Biochemical and Biophysical Research Communications. 678. 1–10. 1 indexed citations
3.
Li, Xin, Shengdan Nie, Xin Hu, et al.. (2021). Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma. Cell Death and Disease. 12(3). 261–261. 20 indexed citations
4.
Song, Tao, et al.. (2021). FLOT2 upregulation promotes growth and invasion by interacting and stabilizing EphA2 in gliomas. Biochemical and Biophysical Research Communications. 548. 67–73. 18 indexed citations
5.
Gu, Jiawei, Gengming Niu, Zhiqing Hu, et al.. (2020). PRELP has prognostic value and regulates cell proliferation and migration in hepatocellular carcinoma. Journal of Cancer. 11(21). 6376–6389. 18 indexed citations
6.
Lin, Jintao, Tao Song, Cong Li, & Weifeng Mao. (2020). GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(5). 118659–118659. 200 indexed citations
8.
Song, Tao, et al.. (2019). NKAP plays an oncogenic function partly through AKT signaling pathway in hepatocellular carcinoma. Neoplasma. 66(5). 792–800. 7 indexed citations
9.
Song, Tao, Xinghua Hou, & Bing Lin. (2019). MicroRNA‑758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/β‑catenin signaling pathway. Oncology Letters. 18(2). 1786–1792. 20 indexed citations
11.
Song, Tao, Xu Zhang, Guoqiang Yang, Yong‐Seok Song, & Wei Cai. (2015). Decrement of miR-199a-5p contributes to the tumorigenesis of bladder urothelial carcinoma by regulating MLK3/NF-κB pathway.. PubMed. 7(12). 2786–94. 24 indexed citations
12.
Liu, Zhikui, Changwei Dou, Yufeng Wang, et al.. (2015). High-mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma. Molecular Medicine Reports. 12(4). 5997–6004. 14 indexed citations
13.
Guo, Hua, et al.. (2014). Silencing of Survivin Using YM155 Inhibits Invasion and Suppresses Proliferation in Glioma Cells. Cell Biochemistry and Biophysics. 71(2). 587–593. 22 indexed citations
14.
Ding, Dacheng, et al.. (2014). Decreased expression of the SPOP gene is associated with poor prognosis in glioma. International Journal of Oncology. 46(1). 333–341. 17 indexed citations
15.
Xia, Wei, Tao Song, Xueting Su, et al.. (2012). MicroRNA-200b Is Overexpressed in Endometrial Adenocarcinomas and Enhances MMP2 Activity by Downregulating TIMP2 in Human Endometrial Cancer Cell Line HEC-1A Cells. Nucleic Acid Therapeutics. 23(1). 29–34. 39 indexed citations
16.
Song, Tao, Xu Zhang, Chunyang Wang, et al.. (2011). Expression of miR-143 reduces growth and migration of human bladder carcinoma cells by targeting cyclooxygenase-2.. PubMed. 12(4). 929–33. 38 indexed citations
17.
Xia, Wei, Jie Li, Shaohua Li, et al.. (2010). MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells. Molecular and Cellular Biochemistry. 344(1-2). 261–266. 60 indexed citations
18.
Song, Tao, Wei Xia, Ningsheng Shao, et al.. (2010). Differential miRNA expression profiles in bladder urothelial carcinomas.. PubMed. 11(4). 905–11. 83 indexed citations
19.
Yang, Xue, Haibin He, Wei Yang, et al.. (2010). Effects of HSP70 antisense oligonucleotide on the proliferation and apoptosis of human hepatocellular carcinoma cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 30(3). 337–343. 1 indexed citations
20.
Song, Tao. (2000). Establishment of cell lines whose hREV3 gene expression was inhibited by transfection of antisense RNA expression plasmids and their biological characteristics. Zhongguo bingli shengli zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026